세포 식별 기술 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Cell Identification Technology Market Summary

The global cell identification technology market size was estimated at USD 5.56 billion in 2025 and is projected to reach USD 12.43 billion by 2033, growing at a CAGR of 10.9% from 2026 to 2033. The market growth is primarily driven by increasing adoption of advanced cell analysis techniques in biomedical research, rising demand for precision medicine, and expanding applications in diagnostics, drug discovery, and regenerative medicine.

Global Cell Identification Technology Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell identification technology market report based on product & service, technology, application, end-use, and region:

• Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
• Reagents & Consumables
• Software
• Services
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Flow Cytometry
• PCR
• Microscopy
• High-Content Screening (HCS)
• Immunohistochemistry (IHC)
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Disease Diagnosis
• Drug Discovery & Development
• Stem Cell Research
• Immunology Research
• Cancer Research
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinical Testing Laboratories
• Academic & Research Institutes
• Other
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service Segment
  • 1.2.2. Technology Segment
  • 1.2.3. Application Segment
  • 1.2.4. End-user Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Cell Identification Technology Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Technological advancements in cell analysis
    • 3.2.1.2. Increasing drug discovery and biopharmaceutical R&D
    • 3.2.1.3. The rising prevalence of cancer and other chronic diseases
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced instruments and reagents
    • 3.2.2.2. Technical complexity and skilled workforce requirements
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenge analysis
• 3.3. Cell Identification Technology Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Cell Identification Technology Market: Product & Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Cell Identification Technology Market Product & Service Movement Analysis
• 4.3. Global Cell Identification Technology Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Reagents & Consumables
  • 4.5.1. Reagents & consumables market estimates and forecasts 2021 to 2033 (USD Million)
• 4.6. Software
  • 4.6.1. Software market estimates and forecasts 2021 to 2033 (USD Million)
• 4.7. Services
  • 4.7.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Cell Identification Technology Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Cell Identification Technology Market Technology Movement Analysis
• 5.3. Global Cell Identification Technology Materials Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 5.4. Flow Cytometry
  • 5.4.1. Flow cytometry market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. PCR
  • 5.5.1. PCR market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Microscopy
  • 5.6.1. Microscopy market estimates and forecasts 2021 to 2033 (USD Million)
• 5.7. High-Content Screening (HCS)
  • 5.7.1. High-Content Screening (HCS) market estimates and forecasts 2021 to 2033 (USD Million)
• 5.8. Immunohistochemistry (IHC)
  • 5.8.1. Immunohistochemistry (IHC) market estimates and forecasts 2021 to 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Other market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Cell Identification Technology Materials Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Cell Identification Technology Market Application Movement Analysis
• 6.3. Global Cell Identification Technology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Disease Diagnosis
  • 6.4.1. Disease diagnosis market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. Drug Discovery & Development
  • 6.5.1. Drug discovery & development market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Stem Cell Research
  • 6.6.1. Stem cell research market estimates and forecasts 2021 to 2033 (USD Million)
• 6.7. Immunology Research
  • 6.7.1. Immunology research market estimates and forecasts 2021 to 2033 (USD Million)
• 6.8. Cancer Research
  • 6.8.1. Cancer research market estimates and forecasts 2021 to 2033 (USD Million)
• 6.9. Others
  • 6.9.1. Other market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Cellular Starting Materials Market: End-user Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Cell Identification Technology Market End-user Movement Analysis
• 7.3. Global Cell Identification Technology Market Size & Trend Analysis, by End-user, 2021 to 2033 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
• 7.5. Hospitals & Clinical Testing Laboratories
  • 7.5.1. Hospitals & clinical testing laboratories market estimates and forecasts 2021 to 2033 (USD Million)
• 7.6. Academic & Research Institutes
  • 7.6.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
• 7.7. Other
  • 7.7.1. Other market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Cell Identification Technology Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2025 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 8.4. North America
  • 8.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 8.5. Europe
  • 8.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.7. Norway
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Regulatory framework
    • 8.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Competitive scenario
    • 8.5.8.3. Regulatory framework
    • 8.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.9. Denmark
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Competitive scenario
    • 8.5.9.3. Regulatory framework
    • 8.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 8.8. MEA
  • 8.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Competitive scenario
    • 8.8.3.3. Regulatory framework
    • 8.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Competitive scenario
    • 8.8.4.3. Regulatory framework
    • 8.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Competitive scenario
    • 8.8.5.3. Regulatory framework
    • 8.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2025
• 9.4. Company Profiles/Listing
  • 9.4.1. Thermo Fisher Scientific, Inc.
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Danaher Corporation
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Becton, Dickinson and Company
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Merck KGaA
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Agilent Technologies
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Bio-Rad Laboratories
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Miltenyl Biotech
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Illumina
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. QIAGEN
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Sartorius AG
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives